Q-omics provides the consensus-scored RNU6-769P profile across patient tissues and cancer cell-line models. RNU6-769P expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in CESC. Additionally, RNU6-769P RNA expression shows 6,229 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight CESC, and STAD as cancer lineages where RNU6-769P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-769P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-769P survival associations across molecular data types. RNU6-769P RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-769P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	12	CESC (30)	view →

This table ranks reproducible RNU6-769P RNA expression–survival associations across cancer types. High RNU6-769P expression shows unfavorable associations in THCA, PRAD and LIHC, but favorable associations in CESC, STAD and SKCM. The CESC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .029). Together, the overview and detailed table identify CESC as the clearest survival context for RNU6-769P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	1.000	0.724	.029	30	view →
THCA	DFS	Tertile	III,IV	0.193	0.751	.023	27	view →
STAD	OS	Median	III,IV	0.717	0.559	.007	24	view →
SKCM	DFS	Tertile	III,IV	0.882	0.488	.025	21	view →
PRAD	DFS	Tertile	All	0.843	0.939	.001	18	view →
LIHC	DFS	Tertile	II,III,IV	0.081	0.463	.017	18	view →

Pink = unfavorable, green = favorable. all 12 lineages →

RNU6-769P-CESC (OS)

Kaplan–Meier survival curve for RNU6-769P RNA expression in CESC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-769P in patient tissues and cancer cell lines. In patient samples, RNU6-769P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,229	STAD (5673)	view →
Protein (mass-spec)	6,153	LSCC (3370)	view →